Nonalcoholic fatty liver disease is associated with increased GHBP and reduced GH/IGF-I levels-Reference-Cited by-同舟云学术

Nonalcoholic fatty liver disease is associated with increased GHBP and reduced GH/IGF-I levels

Published:2012-09-11 Issue:4 Volume:77 Page:531-536
ISSN:0300-0664
Container-title:Clinical Endocrinology
language:en
Short-container-title:Clin Endocrinol

Author:

Fusco Alessandra,Miele Luca,D’Uonnolo Annalisa,Forgione Alessandra,Riccardi Laura,Cefalo Consuelo,Barini Angela,Bianchi Antonio,Giampietro Antonella,Cimino Vincenzo,Landolfi Raffaele,Grieco Antonio,De Marinis Laura

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Endocrinology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2265.2011.04291.x/fullpdf

Reference36 articles.

1. Biological effects of growth hormone on carbohydrate and lipid metabolism;Vijayakumar;Growth Hormone and IGF Research,2010

2. Growth hormone binding protein. The soluble growth hormone receptor;Baumann;Minerva Endocrinologica,2002

3. Circulating growth hormone binding proteins;Baumann;Journal of Endocrinological Investigation,1994

4. Serum growth hormone-binding protein in obesity: effect of short-term, very low calorie diet and diet-induced weight loss;Rasmussen;Journal of Clinical Endocrinology and Metabolism,1996

5. Effect of obesity on total and free insulin-like growth factor (IGF)-1 and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin and growth hormone;Nam;International Journal of Obesity and Related Metabolic Disorders,1997

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Metabolic Dysfunction-Associated Steatotic Liver Disease on Bone Density and Fragility Fractures: Associations and Mechanisms;Journal of Obesity & Metabolic Syndrome;2024-05-14

2. Insulin-like growth factor binding protein 3 promoter variant (rs2854744) is associated with nonalcoholic fatty liver disease;ARCH ENDOCRIN METAB;2024

3. Complementary role of peripheral and central autonomic nervous system on insulin-like growth factor-1 activation to prevent fatty liver disease;Hepatology International;2023-10-21

4. Growth hormone and nonalcoholic fatty liver disease;Immunometabolism;2023-07

5. Metabolism-Disrupting Chemicals Affecting the Liver: Screening, Testing, and Molecular Pathway Identification;International Journal of Molecular Sciences;2023-01-31